How have COCP and PAVM total returns compared?

Over the past 10 years, COCP delivered -39.76% and PAVM delivered -54.03% annualized total return. Past performance doesn't predict future results.

Cocrystal Pharma, Inc. (COCP) vs PAVmed Inc. (PAVM)

A side-by-side comparison of Cocrystal Pharma, Inc. and PAVmed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

COCP

Cocrystal Pharma, Inc.

$15M

$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PAVM

PAVmed Inc.

$17M

$2.68HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — COCP vs PAVM

growth of $100 · dividends reinvested · last 10y

COCP -99.4% (-39.6%/yr)PAVM -100.0% (-54.0%/yr)COCP compounded faster over this window

Log scale — wide-divergence pair

COCP PAVM

COCP vs PAVM: by the numbers

•PAVM is the larger company ($17M vs $15M market cap).
•Both run net losses; COCP's is the smaller (-3011.52% vs -10794.64% net margin).

Metrics side by side

Valuation

Metric	COCP	PAVM
P/S ratio	46.38	152.45
P/B ratio	14.66	0.55

Profitability

Metric	COCP	PAVM
Gross margin	0.00%	-354.93%
Operating margin	0.00%	-30712.68%
Net margin	-3011.52%	-10794.64%
ROE	-951.92%	-34.50%
ROIC	-497.29%	-73.92%

Growth (annualized)

Metric	COCP	PAVM
Revenue CAGR (5Y)	91.55%	N/A
Total return CAGR (5Y)	-37.50%	-76.55%

Frequently asked

How have COCP and PAVM total returns compared?: Over the past 10 years, COCP delivered -39.76% and PAVM delivered -54.03% annualized total return. Past performance doesn't predict future results.

Go deeper

Full COCP analysis Full PAVM analysis Interactive comparison tool

Dig into the metrics

Cocrystal Pharma ROE PAVmed ROE Cocrystal Pharma operating margin PAVmed operating margin Cocrystal Pharma revenue growth PAVmed revenue growth Cocrystal Pharma free cash flow PAVmed free cash flow

Cocrystal Pharma & PAVmed appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.